ALX ONCOLOGY HOLDINGS INC Basic Shares Outstanding (Weighted Average)
ALX ONCOLOGY HOLDINGS INC (ALXO) reported Basic Shares Outstanding (Weighted Average) of 135.64 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- ALX ONCOLOGY HOLDINGS INC weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 135.64M shares, a 153.79% increase year-over-year.
- ALX ONCOLOGY HOLDINGS INC weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 104.57M shares, a 95.98% increase year-over-year.
- ALX ONCOLOGY HOLDINGS INC weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 54.28M shares, a 0.39% increase year-over-year.
- ALX ONCOLOGY HOLDINGS INC weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 53.58M shares, a 1.68% increase year-over-year.
- ALX ONCOLOGY HOLDINGS INC weighted average number of shares outstanding, basic for fiscal 2025 was 53.66M shares, a 2.84% increase from fiscal 2024.
- ALX ONCOLOGY HOLDINGS INC weighted average number of shares outstanding, basic for fiscal 2024 was 52.17M shares, a 21.37% increase from fiscal 2023.
- ALX ONCOLOGY HOLDINGS INC weighted average number of shares outstanding, basic for fiscal 2023 was 42.99M shares, a 5.62% increase from fiscal 2022.
- ALX ONCOLOGY HOLDINGS INC weighted average number of shares outstanding, basic for fiscal 2022 was 40.70M shares, a 0.97% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 135.64M shares 10-Q · filed 2026-08-06 | 120.10M shares 10-Q · filed 2026-08-06 | 98.16M shares derived: average of 3 quarters · filed 2026-08-06 | 87.02M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 104.57M shares 10-Q · filed 2026-05-08 | 79.43M shares derived: average of 2 quarters · filed 2026-05-08 | 70.81M shares derived: average of 3 quarters · filed 2026-05-08 | 66.47M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 54.28M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | 53.93M shares derived: average of 2 quarters · filed 2026-03-09 | 53.77M shares derived: average of 3 quarters · filed 2026-08-06 | 53.66M shares 10-K · filed 2026-03-09 |
| 2025-09-30 | 53.58M shares 10-Q · filed 2025-11-07 | 53.51M shares derived: average of 2 quarters · filed 2026-08-06 | 53.45M shares 10-Q · filed 2025-11-07 | 53.61M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 53.45M shares 10-Q · filed 2026-08-06 | 54.03M shares 10-Q · filed 2026-08-06 | 53.62M shares derived: average of 3 quarters · filed 2026-08-06 | 53.39M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 53.36M shares 10-Q · filed 2026-05-08 | 53.71M shares derived: average of 2 quarters · filed 2026-05-08 | 53.37M shares derived: average of 3 quarters · filed 2026-05-08 | 52.99M shares derived: average of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | 54.07M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | 53.38M shares derived: average of 2 quarters · filed 2026-03-09 | 52.86M shares derived: average of 3 quarters · filed 2026-03-09 | 52.17M shares 10-K · filed 2026-03-09 |
| 2024-09-30 | 52.69M shares 10-Q · filed 2025-11-07 | 52.26M shares derived: average of 2 quarters · filed 2025-11-07 | 51.54M shares 10-Q · filed 2025-11-07 | 50.93M shares derived: average of 4 quarters · filed 2026-03-09 |
| 2024-06-30 | 51.83M shares 10-Q · filed 2025-08-12 | 50.97M shares 10-Q · filed 2025-08-12 | 50.34M shares derived: average of 3 quarters · filed 2026-03-09 | 48.04M shares derived: average of 4 quarters · filed 2026-03-09 |
| 2024-03-31 | 50.12M shares 10-Q · filed 2025-05-08 | 49.59M shares derived: average of 2 quarters · filed 2026-03-09 | 46.78M shares derived: average of 3 quarters · filed 2026-03-09 | 45.30M shares derived: average of 4 quarters · filed 2026-03-09 |
| 2023-12-31 | 49.06M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | 45.10M shares derived: average of 2 quarters · filed 2026-03-09 | 43.70M shares derived: average of 3 quarters · filed 2026-03-09 | 42.99M shares 10-K · filed 2026-03-09 |
| 2023-09-30 | 41.15M shares 10-Q · filed 2024-11-07 | 41.01M shares derived: average of 2 quarters · filed 2024-11-07 | 40.96M shares 10-Q · filed 2024-11-07 | 40.91M shares derived: average of 4 quarters · filed 2025-03-06 |
| 2023-06-30 | 40.88M shares 10-Q · filed 2024-08-12 | 40.87M shares 10-Q · filed 2024-08-12 | 40.83M shares derived: average of 3 quarters · filed 2025-03-06 | 40.81M shares derived: average of 4 quarters · filed 2025-03-06 |
| 2023-03-31 | 40.86M shares 10-Q · filed 2024-05-09 | 40.80M shares derived: average of 2 quarters · filed 2025-03-06 | 40.79M shares derived: average of 3 quarters · filed 2025-03-06 | 40.76M shares derived: average of 4 quarters · filed 2025-03-06 |
| 2022-12-31 | 40.75M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | 40.75M shares derived: average of 2 quarters · filed 2025-03-06 | 40.73M shares derived: average of 3 quarters · filed 2025-03-06 | 40.70M shares 10-K · filed 2025-03-06 |
| 2022-09-30 | 40.75M shares 10-Q · filed 2023-11-13 | 40.72M shares derived: average of 2 quarters · filed 2023-11-13 | 40.68M shares 10-Q · filed 2023-11-13 | 40.65M shares derived: average of 4 quarters · filed 2024-03-07 |
| 2022-06-30 | 40.69M shares 10-Q · filed 2023-08-10 | 40.65M shares 10-Q · filed 2023-08-10 | 40.61M shares derived: average of 3 quarters · filed 2024-03-07 | 40.56M shares derived: average of 4 quarters · filed 2024-03-07 |
| 2022-03-31 | 40.62M shares 10-Q · filed 2023-05-11 | 40.57M shares derived: average of 2 quarters · filed 2024-03-07 | 40.51M shares derived: average of 3 quarters · filed 2024-03-07 | 40.45M shares derived: average of 4 quarters · filed 2024-03-07 |
| 2021-12-31 | 40.53M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | 40.46M shares derived: average of 2 quarters · filed 2024-03-07 | 40.39M shares derived: average of 3 quarters · filed 2024-03-07 | 40.31M shares 10-K · filed 2024-03-07 |
| 2021-09-30 | 40.40M shares 10-Q · filed 2022-11-08 | 40.32M shares derived: average of 2 quarters · filed 2022-11-08 | 40.23M shares 10-Q · filed 2022-11-08 | 39.62M shares derived: average of 4 quarters · filed 2023-03-09 |
| 2021-06-30 | 40.25M shares 10-Q · filed 2022-08-08 | 40.15M shares 10-Q · filed 2022-08-08 | 39.36M shares derived: average of 3 quarters · filed 2023-03-09 | 36.94M shares derived: average of 4 quarters · filed 2023-03-09 |
| 2021-03-31 | 40.06M shares 10-Q · filed 2021-05-17 | 38.92M shares derived: average of 2 quarters · filed 2023-03-09 | 35.83M shares derived: average of 3 quarters · filed 2023-03-09 | 27.67M shares derived: average of 4 quarters · filed 2023-03-09 |
| 2020-12-31 | 37.78M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | 33.72M shares derived: average of 2 quarters · filed 2023-03-09 | 23.54M shares derived: average of 3 quarters · filed 2023-03-09 | 18.49M shares 10-K · filed 2023-03-09 |
| 2020-09-30 | 29.66M shares 10-Q · filed 2021-11-12 | 16.41M shares derived: average of 2 quarters · filed 2021-11-12 | 12.05M shares 10-Q · filed 2021-11-12 | 9.77M shares derived: average of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | 3.16M shares 10-Q · filed 2021-08-12 | 3.16M shares 10-Q · filed 2021-08-12 | 3.14M shares derived: average of 3 quarters · filed 2022-02-28 | 3.13M shares derived: average of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | 3.14M shares 10-Q · filed 2021-05-17 | 3.13M shares derived: average of 2 quarters · filed 2022-02-28 | 3.12M shares derived: average of 3 quarters · filed 2022-02-28 | 3.11M shares derived: average of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | 3.12M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | 3.11M shares derived: average of 2 quarters · filed 2022-02-28 | 3.10M shares derived: average of 3 quarters · filed 2022-02-28 | 3.08M shares 10-K · filed 2022-02-28 |
| 2019-09-30 | 3.10M shares 10-Q · filed 2020-11-12 | 3.09M shares derived: average of 2 quarters · filed 2020-11-12 | 3.06M shares 10-Q · filed 2020-11-12 | |
| 2019-06-30 | 3.09M shares 10-Q · filed 2020-08-27 | 3.05M shares 10-Q · filed 2020-08-27 | ||
| 2018-12-31 | 2.75M shares 10-K · filed 2021-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |